These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25449870)

  • 1. Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice.
    Doyle KP; Quach LN; Arceuil HE; Buckwalter MS
    Neurosci Lett; 2015 Jan; 584():236-40. PubMed ID: 25449870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging applications for ferumoxytol as a contrast agent in MRI.
    Bashir MR; Bhatti L; Marin D; Nelson RC
    J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
    Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
    J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke.
    Walter HL; Walberer M; Rueger MA; Backes H; Wiedermann D; Hoehn M; Neumaier B; Graf R; Fink GR; Schroeter M
    Neuroscience; 2015 Apr; 292():71-80. PubMed ID: 25701708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
    Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.
    McConnell HL; Schwartz DL; Richardson BE; Woltjer RL; Muldoon LL; Neuwelt EA
    Nanomedicine; 2016 Aug; 12(6):1535-42. PubMed ID: 27071335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasmall Superparamagnetic Iron Oxide Imaging Identifies Tissue and Nerve Inflammation in Pain Conditions.
    Shen S; Ding W; Ahmed S; Hu R; Opalacz A; Roth S; You Z; Wotjkiewicz GR; Lim G; Chen L; Mao J; Chen JW; Zhang Y
    Pain Med; 2018 Apr; 19(4):686-692. PubMed ID: 29177411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes of inflammation and apoptosis in cerebral ischemia‑reperfusion injury in mice investigated by ferumoxytol‑enhanced magnetic resonance imaging.
    Zhuang L; Kong Y; Yang S; Lu F; Gong Z; Zhan S; Liu M
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USPIO-Enhanced MRI Neuroimaging: A Review.
    Gkagkanasiou M; Ploussi A; Gazouli M; Efstathopoulos EP
    J Neuroimaging; 2016; 26(2):161-8. PubMed ID: 26932522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
    Neuwelt EA; Hamilton BE; Varallyay CG; Rooney WR; Edelman RD; Jacobs PM; Watnick SG
    Kidney Int; 2009 Mar; 75(5):465-74. PubMed ID: 18843256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging.
    Saleh A; Wiedermann D; Schroeter M; Jonkmanns C; Jander S; Hoehn M
    NMR Biomed; 2004 Jun; 17(4):163-9. PubMed ID: 15229929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study.
    Hasan DM; Mahaney KB; Magnotta VA; Kung DK; Lawton MT; Hashimoto T; Winn HR; Saloner D; Martin A; Gahramanov S; Dósa E; Neuwelt E; Young WL
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1032-8. PubMed ID: 22328774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferumoxytol Is Not Retained in Kidney Allografts in Patients Undergoing Acute Rejection.
    Aghighi M; Pisani L; Theruvath AJ; Muehe AM; Donig J; Khan R; Holdsworth SJ; Kambham N; Concepcion W; Grimm PC; Daldrup-Link HE
    Mol Imaging Biol; 2018 Feb; 20(1):139-149. PubMed ID: 28411307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
    Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE
    Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USPIOs as targeted contrast agents in cardiovascular magnetic resonance imaging.
    Lu Y; Huang J; Neverova NV; Nguyen KL
    Curr Cardiovasc Imaging Rep; 2021 Feb; 14(2):. PubMed ID: 33824694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease.
    Kowalczyk M; Banach M; Rysz J
    J Nephrol; 2011; 24(6):717-22. PubMed ID: 21956770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach.
    Yilmaz A; Dengler MA; van der Kuip H; Yildiz H; Rösch S; Klumpp S; Klingel K; Kandolf R; Helluy X; Hiller KH; Jakob PM; Sechtem U
    Eur Heart J; 2013 Feb; 34(6):462-75. PubMed ID: 23103659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke.
    Saleh A; Schroeter M; Ringelstein A; Hartung HP; Siebler M; Mödder U; Jander S
    Stroke; 2007 Oct; 38(10):2733-7. PubMed ID: 17717318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
    Poittevin M; Deroide N; Azibani F; Delcayre C; Giannesini C; Levy BI; Pocard M; Kubis N
    J Neuroimmunol; 2013 Jan; 254(1-2):55-62. PubMed ID: 23026222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults.
    Storey P; Lim RP; Chandarana H; Rosenkrantz AB; Kim D; Stoffel DR; Lee VS
    Invest Radiol; 2012 Dec; 47(12):717-24. PubMed ID: 23070094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.